中国药房2016，Vol.27Issue(26)：3613-3616,4.DOI:10.6039/j.issn.1001-0408.2016.26.04
我院外科2013－2014年参附注射液使用分析
Analysis of the Utilization of Shenfu Injection in Surgery Department of Our Hospital from 2013 to 2014
摘要
Abstract
OBJECTIVE:To know the utilizatior of Shenfu injection(SFI)in our hospital,and provide reference for ratio-nal use of SFI. METHODS:In respective study,patients received SFI from the Hospital Information System(HIS)in surgery department in our hospital from Jan. 2013 to Dec. 2014 were analyzed statistically in aspects of general situation,indications, usage and dosage,course of treatment,drug combination,etc. And the incidence of ADR/ADE was monitored. RESULTS:The 1 247 surgery inpatients used SFI distributed in thyroid and galactophore department(634 cases),comprehensive minimal-ly invasive department (292 cases),gastrointestinal surgery department (250 cases),urology department (64 cases) and car-diothoracic surgery department(7 cases),including 466 male and 781 female,the ratio of male to female was 1∶1.68,aver-age age was 58.50 years;it mainly used in perioperative medication (78.11%) and treated for tumors (11.23%),treatment course concentrated on 2-7 d(71.45%),dosage mainly was 100 ml(70.01%);combination medication were mainly pantopra-zole sodium,Fructus bruceae injection,Xueshuantong for injection(lyophilized),etc. The nonstandard phenomenon was exist-ed in indications,dosage,solvent selection,medication frequency,drug combination,etc. There were no obvious ADR/ADE related to SFI. CONCLUSIONS:More attention must be paid to the irrational use of SFI in surgery clinic of our hospital,the safety of traditional Chinese medicine injection in clinical use should be correctly understood,achieve dialectical therapy and rational drug use.关键词
参附注射液/外科/用药分析/合理用药Key words
Shenfu injection/Surgery/Analysis of medication/Rational drug use分类
医药卫生引用本文复制引用
吴文,尹克鑫,范鲁雁..我院外科2013－2014年参附注射液使用分析[J].中国药房,2016,27(26):3613-3616,4.基金项目
安徽省“十二五”临床重点专科建设计划（No.卫科秘〔2013〕228号）；广东省药品不良反应监测中心药品上市后再评价研究项目 （）
